Rous sarcoma virus (RSV) and its relatives are unique in that they appear to encode their viral protease in the gag reading frame. As a result, this 124-amino-acid sequence is found at the carboxy terminus of each Gag precursor molecule and, upon ribosome frameshifting, embedded within each Gag-Pol molecule. However, rigorous proof has never been obtained for the activity of this 124-amino-acid Gag domain during virion assembly in vivo. If the active protease actually included amino acids encoded downstream in the pol reading frame, then the sequence organization would be more in line with those of other retroviruses. To examine this issue, mutations that disrupt the addition of amino acids by ribosome frameshifting were analyzed for their effects on particle assembly and Gag processing in a mammalian expression system (J. W. Wills, R. C. Craven, and J. A. Achacoso, J. Virol. 63:4331-4343, 1989). A 2-base substitution which created a nonsense mutation in the pol reading frame and was predicted to disrupt the hairpin structure of the ribosome frameshift signal had no effect on particle assembly or Gag processing, definitively showing that downstream amino acids are unnecessary. Mutations that fused the gag and pol reading frames to place 85 amino acids at the carboxy terminus of Gag hindered particle assembly and totally abolished the activity of the protease. A smaller fusion protein containing only the seven-amino-acid spacer peptide that links Gag and reverse transcriptase allowed particle formation but slowed processing. The reduced rate of processing exhibited by this mutant also revealed a previously unnoticed series of late maturation steps associated with the RSV capsid (CA) protein. Another mutant containing two substituted amino acids plus one additional amino acid at the carboxy terminus of protease nearly abolished processing. Together, these results demonstrate the importance of the carboxy terminus for proteolytic activity and suggest that this end must be unrestrained for optimal activity. If this hypothesis is correct, then the RSV protease may be encoded at the end of gag simply to ensure the production of a free carboxy terminus by translational termination.
The major internal structural proteins of all retroviruses are synthesized as polyprotein precursors which are proteolytically cleaved during virion morphogenesis. Translation of the gag and pol sequences in the unspliced viral RNA results in the synthesis of the Gag polyprotein precursor and, as a result of ribosomal frameshifting or suppression of a termination codon at the end of gag, the Gag-Pol precursor. The Gag protein drives particle formation at the plasma membrane (2, 24, 30) , while the Gag-Pol protein provides the enzymatic activities (reverse transcriptase [RT] and integrase [IN] ) needed for the subsequent synthesis and integration of the proviral DNA in the host cell (26) . Because the frequency of frameshifting or termination suppression is low (5 to 10%) in all retroviruses (6) , a great excess of Gag is produced relative to Gag-Pol. It is widely believed that the virus-encoded protease (PR) carries out all the cleavages on the Gag and Gag-Pol precursors and that these occur very late in, or after, the budding process (for recent reviews, see references 2, 18, and 23) .
Many features of the retroviral proteases are highly conserved. For example, they are members of the aspartic acid protease family, and all require the formation of a dimer to assemble the active site (8, 19) . Also, the crystal structures of two retroviral proteases, that of human immunodeficiency virus type 1 (HIV-1) and that of Rous sarcoma virus (RSV), have been determined and found to be very similar (13, 15, conserved.
In spite of these common features, there are some quite interesting differences between retroviral proteases. With regard to crystal structure, for example, the RSV protease contains extra loops that are not found in the structure of the smaller protease of HIV-1 (23, 32) . Also, while all the other proteases contain the characteristic Asp-Thr-Gly sequence in the active site, Thr is replaced with Ser in the RSV protease (19) . But perhaps the most striking differences of all are the amounts of protease that various retroviruses produce and the distribution of the protease domain among the polyprotein precursors. Sequence analysis of cloned retroviral genomes has shown that the PR-coding sequence may be located in either the gag reading frame, the pol reading frame, or a third frame, depending on the particular virus examined. In most viruses (e.g., HIV-1 and murine leukemia virus), PR is encoded at the 5' end of the pol gene and is expressed only as part of the Gag-Pol fusion protein. In this situation, the protease is completely embedded within the polyprotein and therefore must be cleaved, presumably in an autocatalytic manner, to create both its amino and carboxy termini during release from the precursor. In the cases of mouse mammary tumor virus and human T-cell lymphotropic virus types I and II, the protease is encoded in the third reading frame between gag and pol such that PR is synthe-LOCATION OF RSV PROTEASE 273 sized both as a Gag-PR precursor with a free carboxy terminus and embedded in a Gag-PR-Pol precursor (7) .
In contrast to all other retroviruses, RSV and its relatives in the avian sarcoma-leukosis virus (ASLV) family encode a protease at the 3' end of gag; therefore, this protease is found on the carboxy terminus of every Gag molecule and, by ribosomal frameshifting, embedded within every Gag-Pol molecule. While the protease in Gag is linked to the NC protein at its amino terminus, translation termination results in a free carboxy-terminal end (21) . The protease in Gag-Pol is also linked to NC, but its carboxy terminus is linked to RT by means of a short (seven-amino-acid) spacer peptide (see Fig. 1; 22) . As a consequence of the unique gene organization of the ASLV family, the protease of these viruses is produced in an equimolar amount with both of its substrates, the Gag and Gag-Pol precursors, and with the major core proteins (matrix [MA], p10, capsid [CA] , and NC) that result from its activity on Gag.
It is not understood why RSV has evolved to have protease contained within each of its Gag and Gag-Pol molecules. It has been suggested that sequences encoded in the downstream pol reading frame might be required for activation of the protease during the process of particle formation (18) . That is, it is possible that the protease located in the Gag precursor, though apparently active in vitro (27) and in Escherichia coli systems (11) , is inactive in vivo. If this were the case, then the sequence organization of RSV would be more like that of all other retroviruses.
The experiments described in this report were designed to rigorously determine if the 124-amino-acid protease contained within the RSV Gag protein is sufficient for Gag processing during particle formation. By using oligonucleotide-directed mutagenesis to introduce stop codons and frameshift mutations at the gag-pol junction, a variety of Gag derivatives having differing amounts of pol-encoded amino acids at their carboxy termini were created. The mutants were analyzed in mammalian cells by using a previously described, simian virus 40 (SV40)-based, transient expression vector. For the particles that are produced in this system, their rate of release into the growth medium, their morphological appearance, and the electrophoretic mobilities of their mature cleavage products are all identical to those of authentic RSV (29, 30) . The results presented here demonstrate that neither the spacer peptide nor portions of Pol are necessary for RSV protease activity in vivo and that sequences fused to the carboxy terminus of PR appear to be inhibitory to the processing pathway.
MATERIALS AND METHODS
DNAs and cells. The wild-type RSV gag gene was obtained from pATV-8, a molecular clone containing an infectious, sequenced copy of the RSV Prague C genome (22) . Standard protocols were used for all of the DNA manipulations (20) . MGAG, the recombinant M13 bacteriophage containing the gag gene and used for the mutagenesis, has been described previously (30) . All phage stocks were routinely propagated in E. coli MV1190 (20) grown in LB medium. The SV40-based expression vector, pSV.Myrl, used to express the mutant gag genes in mammalian cells, has been described previously (30) . All recombinant plasmids were propagated in E. coli with LB medium containing ampicillin (25 pLg/ml). SV40-transformed African green monkey kidney cells (COS-1) were grown in Dulbecco's modified Eagle's medium (GIBCO Laboratories) supplemented with 3% fetal bovine serum and 7% calf bovine serum (HyClone, Inc.).
Oligonucleotide-directed mutagenesis. The uracil-substituted, single-stranded DNA template used for the mutagenesis reactions was isolated from MGAG grown in E. coli CJ236, a dut ung strain. Mutations were introduced into the gag-po junction by using synthetic oligonucleotides and the method of Kunkel et al. (12) . The oligonucleotide used to create SR12 was 5'-GCTTGACAAATTTTATAGGG-3'; that used for SR13 was 5'-CACTGTTCTCTAGGTTGCGC-3'; that used for SR14 was 5'-GCTTGACAAATTTAT AGGGTAGGCCACTGTTC-3'; and that used for SR15 was 5'-GCTTGACAAATTTAATAGGG-3' (see Fig. 1 ). Mutant GS-1 was kindly provided by Volker M. Vogt (Cornell University, Ithaca, N.Y.). All the mutations were confirmed by DNA sequencing using the dideoxy-chain termination method.
Transfer of the mutations into the mammalian expression vector. DNA fragments containing the mutations were excised and gel purified from the double-stranded, replicative form MGAG DNAs by digestion with BgiII, which cuts at nucleotide (nt) 1630 in the gag gene, and BssHII, which cuts at nt 2724 in the pol gene. The SV40-based expression vector was also cut with the same two restriction endonucleases, and the larger of the two fragments (missing the gag-pol junction) was gel purified. The mutant fragments were inserted into the vector with T4 DNA ligase (New England BioLabs, Beverly, Mass.), and the recombinant DNAs were transformed into E. coli DH-1. To simplify screening for the desired clones, a derivative of pSV.Myrl, pSV.D371, which contains an EcoRV site within the PR-coding sequence, was used (30) . All the clones were screened for the loss of this site. The presence of the desired mutations in the recombinant clones was also confirmed by DNA sequencing.
Transfection of mammalian cells and metabolic labeling. COS-1 cells were transfected by the DEAE-dextran-chloroquine method, and approximately 48 h later, they were labeled with [35S]methionine for 2.5 h as previously de- scribed (29) (30) (31) .
Cell lysis, immunoprecipitation, and detection of Gag and Gag fusion proteins. The labeling medium was removed from the cells, microcentrifuged to remove loose cells, and mixed with detergents, as previously described (30) . Cell lysates were prepared and the nuclei were discarded also as previously described (30) . Gag-related proteins were immunoprecipitated from the lysate and medium fractions with an excess of rabbit antiserum raised against purified RSV (29) . The antigen-antibody complexes were collected with fixed Staphylococcus aureus cells by standard protocols (5) . All immunoprecipitated proteins were dissolved in sample buffer and separated in 1.5-mm-thick sodium dodecyl sulfate (SDS)-12% polyacrylamide gels as previously described (29, 30) . Gels 10 cm in length were used for most experiments, but to achieve maximal resolution of the triplet of CA-related proteins, gels of 25 cm were required. The positions of labeled proteins in the gels were determined by fluorography using Fluoro-Hance (Research Products International, Inc.) and X-Omat AR5 film (Eastman Kodak Co., Rochester, N.Y.) at -70°C.
RESULTS
The RSV Gag protein, Pr76gag, has been previously shown to contain a protease. The experiments described below were designed to test the hypothesis that amino acids encoded in the pol reading frame are essential for the activity of this protease during viral maturation. Stated another way, the goal of this study was to evaluate whether the protease have constructed insertion mutations to align the gag and pol reading frames and thereby fuse either 7 or 85 amino acids of Pol onto Gag to evaluate the ability of such proteins to function in particle assembly and protease activity.
Mutagenesis strategy. Mutations were introduced by oligonucleotide-directed mutagenesis into the Sacl-HindIll fragment of the RSV Prague C genome carried in an M13 vector, as described in Materials and Methods. The mutations that were obtained are illustrated in Fig. 1 . Restriction fragments containing the mutations were moved into a gag expression vector, pSV.Myrl, for evaluation of the protein products in COS-1 cells (see below). The amino acid sequences that are expected to result from the expression of the different mutants are also shown in Fig. 1 .
Two mutations were created by the introduction of stop codons in the Gag-Pol spacer region to cause premature termination of the gag-pol readthrough product. The first truncation mutant, designated SR13, was made by changing the eighth codon of the Pol reading frame from ACT (Thr) to TAG (stop). Because this 3-nt substitution falls within the loop of the frameshifting signal, as characterized by Jacks et al. (6), we expected that this mutation might have no effect on the efficiency of ribosomal frameshifting. Thus, translation with normal frameshifting at the end of gag should produce Pr769'9 as the predominant product, with small amounts (approximately 5%) of a readthrough product consisting of the Pr769' fused to the seven-amino-acid spacer. Because of the small difference in size (seven amino acids), we were not able to reliably resolve these two products (Fig.  2) . The second truncation mutant, SR14, was created by changing the third codon in the pol reading frame from AGG (Arg) to TAG (stop). Frameshifting was expected to be disrupted by this mutation, since the two nucleotides affected are involved in base pairing within the stem of the ribosome frameshift signal (6) . However, if frameshifting were to continue, then a small fraction of Gag molecules synthesized should consist of Pr769'9 fused to the first two amino acids of the spacer peptide ( Fig. 1) .
Two (+ 1) frameshift mutations were generated by the insertion of single nucleotides at the gag-pol junction to evaluate whether the Gag protease would be proteolytically active when amino acids derived from the spacer peptide and Pol were fused to the carboxy terminus of PR. The first of these mutants, SR12, was produced by a thymidine insertion in the final gag codon. SR15 was created by the insertion of an adenine immediately preceding the gag termination codon (Fig. 1 ). Both changes should have the effect of placing the gag stop codon out of frame and result in the fusion of the gag and pol reading frames. Translation is expected to produce a protein consisting of Pr769'' fused to 86 amino acids of the spacer and Pol, with a single amino acid substitution at the end of the protease sequence in the case of SR12. No Pr769ag should be produced by either mutant. If frameshifting still occurred, then a minor translation product composed of Pr76g plus 28 foreign amino acids encoded by the third reading frame would be expected. However, the frequency with which this species should arise cannot be predicted. Though Jacks et al. (6) have shown that UUU at the site of frameshifting actually increases the efficiency of frameshifting, in SR12 and SR15, the distance between the stem-loop of the frameshifting signal and the actual site of frameshifting has been increased by 1 nt, making it unclear what effect this will have on the frequency of the frameshift event.
Gag-Pol truncation mutants SR13 and SR14. The effects of the SR13 and SR14 mutations on particle formation and proteolytic processing were analyzed by transfection of plasmid DNA containing these alterations into COS-1 cells as described previously (29, 30) . At 48 h posttransfection, the cells were labeled with [35S]methionine for 2.5 h. Gag proteins from the media and cell lysates were immunoprecipitated with an anti-RSV serum, separated by electrophoresis in an SDS-12% polyacrylamide gel, and visualized by fluorography. In this type of assay, assembly-competent Gag proteins, such as the Myrl protein expressed by the parent plasmid, pSV.Myrl, rapidly form particles that are released from the cell (29, 30) , as evidenced by the accumulation of Gag proteins in the labeling medium ( Fig. 2A, Media lane 6) . When the Gag protein carries an active PR, as is the case with Myrl, processing to release the mature proteins is very rapid, and generally no uncleaved precursor can be seen in the medium. Rather, the mature cleavage products CA (p27) and PR (p15) are evident. Under these labeling conditions, the MA protein appears as a 23-kDa species, composed of MA and a small peptide named p2 (29, 30) , which runs slightly faster than the CA bands.
When SR13 and SR14 were expressed in COS-1 cells, particle formation appeared to be equally efficient to that of Myrl, since the amounts of Gag products found in the medium samples are similar ( Fig. 2A, lanes 3 and 5, and Fig.  2B, lanes 2 and 3) . That these proteins were contained in viruslike particles was confirmed by sedimentation analysis through sucrose (data not shown). Furthermore, the electrophoretic mobilities of the mature Gag products present in the medium of SR13-and SR14-transfected cells appeared virtually identical to those of Myrl; processing was complete and only the proteolytic products were present. These results strongly suggest that the translation of a gag-pol readthrough product is not necessary for the function of the RSV gag-encoded protease. SR13 clearly demonstrates that nothing downstream of the spacer peptide is essential. In the case of SR14, if any amino acids of the spacer peptide are fused to PR, which seems unlikely, the fusion must be limited to two amino acids in a small fraction of the total translation products. Thus, it appears that the 124-aminoacid PR encoded by gag is sufficient for catalyzing the maturation of the Gag precursor in vivo.
Gag-Pol fusion mutants SR12 and SR15. These two mutants were designed to determine whether the protease could still function if the major translation product were a fusion protein consisting of Gag fused to the first 85 amino acids encoded in the pol reading frame. Upon expression of SR12 and SR15, no proteins of a length corresponding to Pr76gag were observed in either the lysates or media, as predicted ( Fig. 2A, lane 2, and Fig. 2C, lanes 2 and 3) . Instead, a protein product of the size expected for the fusion product was present. The behavior of this protein for each of the two mutants was identical. Large amounts of the uncleaved precursor accumulated in the cells, but very little was released into the medium and no cleavage products were observed in the medium. In a pulse-chase labeling experiment with mutant SR12, no processing of this polyprotein was observed even after a 6-h chase (Fig. 3) . Thus, it is clear that fusion of even a small portion of Pol (85 amino acids) to the carboxy terminus of the RSV protease hinders particle LOCATION OF RSV PROTEASE formation dramatically when this protein is expressed as the major translation product. Further, in those particles that are produced, the protease is completely inactive.
We next sought to determine whether the fusion of a shorter peptide, the seven amino acids of the spacer, onto the carboxy terminus of Gag would have a similar inhibitory effect on particle formation and protease activity. This was accomplished by combining the SR12 and SR13 mutations to create SR12+13 (Fig. 1) . The behavior of this protein in COS-1 cells is shown in Fig. 2A (lanes 4) and Fig. 3 is able to form particles with an efficiency similar to that of Myrl, as indicated by the large amount of Gag products that were seen in the medium. However, the efficiency of proteolytic processing seemed to be reduced, since a significant amount of uncleaved Gag precursor was released into the medium ( Fig. 2A, Media lane 4) . The pulse-chase labeling experiment whose results are shown in Fig. 3A confirmed this effect. After 15 min of pulse labeling, cleavage products from the wild-type protein (Myrl) were already apparent, whereas the SR12+13 product remained almost entirely in the precursor form in the lysate and medium samples. Though the rate of processing of the SR12+13 protein was reproducibly slower than that of Myrl, within 2 h it appeared to be nearly complete.
We also found that mutant SR12+13 consistently produces readily detectable levels of a processing intermediate that migrates slightly slower than mature PR (Fig. 3B, lane 2), and this species probably corresponds to the protease with the spacer still attached, though definitive proof of this awaits further experimentation. As expected, this band was not found with SR14 (lane 3), but it is occasionally detected in trace amounts in SR13 (lane 1) and the parent Myrl (not shown). In pulse-chase experiments (Fig. 3A) , the band was visible after 2 h of chase but disappeared by 6 h to yield mature PR. Since each of the SR12+13 Gag precursors is synthesized with the spacer peptide fused to it, the appearance of a cleavage product of a size similar to that of the wild-type PR implies that cleavage to remove the spacer has occurred in spite of the amino acid substitution (Leu to Phe) at the end of PR. This substitution may account for the very slightly slower migration of the mature protease from SR12+13 relative to SR13 and SR14 (Fig. 3B) .
CA maturation. In addition to the slower rate of Gag processing, a subtle difference was noted in the electrophoretic profile of the CA (p27) protein produced by mutant SR12+13 relative to the wild-type products. Under our standard conditions for [35S]methionine labeling and gel electrophoresis, the wild-type CA protein is generally resolved into a set of three closely migrating bands of approximately equal intensity (Fig. 3C, lane 4) . All 15 min and then chased in medium with unlabeled methionine for various times. To best resolve the CA bands, proteins immunoprecipitated with anti-RSV serum were electrophoresed in a long (25-cm) SDS-polyacrylamide gel (12% acrylamide). After a 15-min chase, only the fastest-migrating CA species was detected in the lysate and medium (Fig. 4) . After a 60-min chase, the other two CA species became apparent, but at a level that was reduced relative to the initial species. This unequal distribution is reminiscent of the altered pattern of mutant SR12+13 (Fig. 3C) . After a 3-h chase, all three species of CA were evident in equal proportions (Fig.  4) . With still longer chase times (6 h), only the upper two CA species remained, even in the case of mutant SR12+13 (Fig.  3A) .
From these experiments, we conclude that CA maturation initially involves a very rapid cleavage event which, surprisingly, produces the fastest-migrating species, designated CA1, and this is followed by a very slow series of events in which the two slower-migrating species, CA2 and CA3, arise. A determination of the exact nature of CAL, CA2, and CA3 awaits further investigation, but the data presented here suggest the hypothesis that CA2 and CA3 are proteolytically derived from CAl since a mutation (SR12+13) that slows protease activity also slows the maturation of CA (see Discussion).
Alteration of the carboxy terminus of PR. Another Gag mutant, GS1, with an altered carboxy-terminal end was evaluated for protease activity during particle formation in COS-1 cells. The relevant nucleotide sequence for this mutant, which was a serendipitous result of an in vitro mutagenesis experiment, is shown in Fig. 1 carries a substitution of the last two amino acids of Gag (Asp to Ile and Leu to Ser) and the addition of a foreign amino acid (Ser) at the carboxy terminus. Termination should occur at the second codon within the duplicated sequence. As a result of the duplication, the ribosomal frameshifting signal has been shifted downstream. Consistent with this sequence, no readthrough products can be detected (data not shown). That GS1 was fully capable of particle formation, evident by the accumulation of Gag precursor in the medium, is shown in Fig. 5 . Processing, however, appeared to occur very inefficiently, since only a small amount of PR was observed. Longer exposures revealed trace amounts of the Gag cleavage products, but after a long chase, additional processing did not appear to take place (data not shown).
These results, together with those obtained with mutants SR12 and SR12+13 and described above, demonstrate the importance of a free and unmodified carboxy terminus for correct proteolytic activity in vivo.
DISCUSSION
Unlike all other replication-competent retroviruses, RSV and the other members of the ASLV group encode a protease in the gag reading frame. The experiments reported here clearly demonstrate that this protease is sufficient for the in vivo processing of the Gag precursor during particle formation and that additional amino acids, encoded in the downstream pol reading frame, are not important.
Why is the RSV protease encoded by the gag gene? The large amount of protease produced by RSV suggests that it could play a structural role in addition to its catalytic function. Little is known about the position of PR within the virion. Though some evidence suggests that it is located in the space between the viral membrane and the capsid (1), it is not known whether the protease forms a distinct structure made up of repeating PR subunits, in a manner similar to the components of the capsid or nucleocapsid. In any case, if the RSV protease does play a structural role, that function is not required for particle formation, since budding continues at the same high rate even if the protease domain is deleted from the RSV Gag protein (29) . Alternatively, one could imagine that PR plays a role in the folding and positioning of the cleavage sites within the Gag precursor so that they remain accessible inside the environment of the immature virion. Experiments to begin addressing this idea would require that the RSV protease be packaged into particles at lower concentrations, perhaps by moving its coding sequence into the pol frame.
Reduced levels of RSV protease might be expected to impede Gag processing because this enzyme appears to have an inherently lower level of activity than other (non-ASLV) proteases (10) . Thus, the RSV protease might be needed in large amounts simply to facilitate complete processing.
Interestingly, sequence comparison of all known retroviral and cellular aspartic acid proteases has revealed that each contains the sequence Asp-Thr-Gly in its active site, except the ASLV protease, in which Thr is replaced with Ser (19) .
(The only other sequence in which Ser is found at this position is in the Gag-like protein of hamster intracisternal A particles [17] .) It would be quite interesting to determine whether the RSV protease becomes more active, and capable of cleaving Gag at lower concentrations, if Ser-38 is changed to Thr.
Another possible reason why the RSV protease might be needed on every Gag molecule is that one or more cleavages might occur only in cis. That is, any two precursors that interact to form a dimeric protease might be cleaved intramolecularly only at certain positions by that same protease. However, in vitro cleavage of the Gag precursor (27) or peptide substrates (9) (10) (11) by the RSV protease has been demonstrated; thus, PR is not limited to a cis cleavage ability. Moreover, we have recently obtained evidence that shows that the RSV protease is capable of cleaving in trans during particle formation in complementation experiments (to be presented elsewhere).
The hypothesis that we presently favor for why the RSV protease is encoded by gag is that this position ensures that a free carboxy-terminal end will be created by translational termination. This appears to be important because the activity of the protease is greatly impeded or eliminated if amino acids are attached to its carboxy terminus. This was shown by mutants SR12 and SR15, in which the addition of 85 pol-encoded amino acids to the end of the Gag precursor completely halted processing. Because this polypeptide fragment from RT is unlikely to have the capacity to fold properly, one could argue that it is likely to interfere with the proper folding of the immediately adjacent PR domain. However, even when just the seven-amino-acid spacer peptide was attached to the Gag protein (in mutant SR12+13), there appeared to be an inhibition of the protease, though we have not ruled out the possibility that the substitution of Leu with Phe at residue 124 accounted for the reduced activity. If our free-end hypothesis is correct, then the protease embedded within the Gag-Pol precursor would be expected to have little or no activity and thus to be unable to generate its amino or carboxy terminus by an autocatalytic cleavage event. Experiments to test this idea are in progress using our mammalian expression system.
Whether or not the free-end hypothesis is correct, it is clear that the amino acids at the very amino terminus of the ASLV protease are critical for activity. Minor alteration of this sequence in mutant GS-1 almost completely abolished protease activity. Similar results have been observed with the HIV-1 protease (4, 14) . The crystal structures of the RSV and HIV-1 proteases are superimposable in this region and suggest that the carboxy termini, which form antiparallel P strands with the amino termini, are critical for dimerization (13, 15, 32) .
Why do additional amino acids interfere with particle formation? Mutations SR12 and SR15 had a profound inhibitory effect on particle formation. Both of these resulted in the addition of 85 residues of Pol to the carboxy terminus of Gag, creating fusion proteins of 786 amino acids. It is not clear what accounts for the interference in particle formation. It may be that the additional amino acids cannot be accommodated easily within the limited internal space of the particle. This seems unlikely because in our laboratory iso-1-cytochrome c from Saccharomyces cerevisiae has been fused to the carboxy-terminal region of the RSV Gag protein to produce a chimeric protein that is only 31 amino acids shorter than the SR12 and SR15 proteins, and this Gag fusion protein is very efficient at making particles (29) . Another possibility, mentioned above in regard to the lack of processing of SR12 and SR15, is that the addition of an improperly folded, truncated segment of the Pol domain might inhibit the folding of Gag and consequently particle formation. Though we cannot rule this possibility out, we point out that in the Gag-cytochrome fusion, the foreign sequence was joined at a position internal to the protease domain and the remaining, truncated portion of protease did not interfere. Moreover, we have recently fused the RSV gag and pol reading frames to express high levels of the full-length Gag-Pol protein in the absence of Gag-only molecules and found that these are also incapable of particle formation (to be presented elsewhere); identical results have been obtained with the Gag-Pol protein of murine leukemia virus (3) . A third possibility is that the sequence encoded immediately downstream of gag contains a negative regulatory domain that prevents Gag-Pol molecules from driving particle formation in the absence of Gag-only molecules. Though there is no precedent for this sort of a negative regulatory function, it would seem advantageous to regulate the maximal amounts of RT and IN that are packaged into a virion.
What is the role of the spacer peptide region? It appears that the spacer peptide does not play a direct role in the activity or regulation of the RSV protease. It is also irrelevant for particle formation. However, the coding sequence for this peptide coincides with the 5' side of the stem region of the ribosome frameshift signal (6) . Mutations made in this region that destabilize base pairing in the stem reduce frameshifting, and compensatory mutations that restore base pairing reinstate frameshifting. Thus, it seems most likely that the RNA sequence in this region is much more important than the translational product. Nevertheless, activation of the RSV reverse transcriptase appears to require its release from the Gag-Pol precursor (25) 
